Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Mission Bay Capital is a venture capital firm founded in 2009 and based in San Francisco, California. The firm emerged from the QB3 research institute at the University of California, which provides a strong university-to-venture pipeline. Mission Bay Capital focuses on supporting entrepreneurial scientists in their quest to create impactful companies that address significant challenges, particularly in chronic diseases and environmental issues.
Currently, Mission Bay Capital manages a fund size of $60 million and has invested in 45 companies. The firm operates an incubator known as MBC BioLabs, which offers state-of-the-art facilities and resources to help startups thrive from day one. Over the years, Mission Bay Capital has established itself as a key player in the life sciences sector, contributing to the launch of numerous successful companies.
Mission Bay Capital primarily invests in early-stage companies within the life sciences sector, specifically targeting biotech and healthcare. The firm focuses on the pre-seed, seed, and seed-plus stages, providing critical funding to help entrepreneurs validate their technologies. The check sizes are not explicitly stated, but the firm emphasizes the importance of supporting innovative startups that tackle complex health and environmental problems.
Through its incubator, MBC BioLabs, Mission Bay Capital offers access to advanced facilities that enable startups to conduct experiments from their first day. This support is designed to enhance efficiency and foster innovation among entrepreneurs. The firm looks for founders who are not only passionate about their work but also possess the scientific expertise necessary to drive their companies forward.
Mission Bay Capital has invested in a total of 45 companies, many of which have achieved successful exits. Notable portfolio companies include:
These companies represent a diverse range of innovations within the life sciences sector, showcasing Mission Bay Capital's effective investment strategy and commitment to supporting groundbreaking research and development.
Douglas Crawford, PhD - Managing Partner at Mission Bay Capital and Managing Director of MBC BioLabs. He has overseen investments in over 45 companies and has a strong background in life sciences.
Robert Blazej, PhD - Partner at Mission Bay Capital and Director of MBC BioLabs. He joined the management team with Fund III and has experience as a bio-entrepreneur.
Peter D. Parker - Venture Partner at Mission Bay Capital and Managing General Partner at BioInnovation Capital. He brings extensive experience in venture capital and life sciences.
Linda Eng - Office Manager at Mission Bay Capital and Business Manager at MBC BioLabs. She plays a crucial role in the firm's operations.
Vivian Dang - Controller at Mission Bay Capital, responsible for financial management and reporting.
To pitch to Mission Bay Capital, founders should visit their website at missionbaycapital.com for detailed instructions. The firm prefers pitches that include a clear overview of the technology, the problem it addresses, and the team behind the startup. Founders should be prepared to discuss their business model and market strategy.
Response times can vary, but founders are encouraged to follow up if they do not receive a timely response. Warm introductions are preferred, as they can enhance the chances of securing a meeting with the investment team.
Mission Bay Capital operates MBC BioLabs, an incubator designed to support early-stage life sciences companies. MBC BioLabs provides access to advanced facilities and resources, enabling startups to conduct experiments and accelerate their growth. Startups interested in joining the incubator can apply through the Mission Bay Capital website.
In 2019, Mission Bay Capital announced the closing of its $60 million Fund III, which marked a significant increase from its previous $25 million Fund II. This fund focuses on early-stage investments in life sciences companies.
Mission Bay Capital has been actively promoting its incubator, MBC BioLabs, which has supported the launch of over 138 companies that have collectively raised more than $3.5 billion. The incubator provides state-of-the-art facilities and resources for early-stage biotech companies.
What are Mission Bay Capital's investment criteria?
Mission Bay Capital invests in early-stage life sciences companies, primarily in the biotech and healthcare sectors. The firm focuses on pre-seed, seed, and seed-plus stages, providing funding to help entrepreneurs validate their technologies.
How can I apply or pitch to Mission Bay Capital?
Founders interested in pitching to Mission Bay Capital can visit their website at missionbaycapital.com for more information on the application process.
What makes Mission Bay Capital different from other venture firms?
Mission Bay Capital distinguishes itself by its strong connection to the University of California and its focus on supporting entrepreneurial scientists. The firm operates MBC BioLabs, which provides state-of-the-art facilities and resources for startups.
What is the geographic scope of Mission Bay Capital's investments?
The firm primarily focuses on North American companies, leveraging the innovation ecosystem in the San Francisco Bay Area.
What is Mission Bay Capital's post-investment involvement like?
Mission Bay Capital provides not only financial support but also access to a robust network of advisors and industry partners. The firm is actively involved in helping its portfolio companies grow and succeed.
What is the size of Mission Bay Capital's funds?
Mission Bay Capital currently manages a fund size of $60 million, which is part of its third fund. The firm has previously raised funds of varying sizes, including a $25 million Fund II.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.